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Drug actions can be improved by developing new drug delivery systems, such as the mucoadhesive 
system. These systems remain in close contact with the absorption tissue, the mucous membrane, releasing 
the drug at the action site leading to a bioavailability increase and both local and systemic effects. 
Mucoadhesion is currently explained by six theories: electronic, adsorption, wettability, diffusion, fracture 
and mechanical. Several in vitro and in vivo methodologies are proposed for studying its mechanisms. 
However, mucoadhesion is not yet well understood. The aim of this study was to review the mechanisms 
and theories involved in mucoadhesion, as well as to describe the most-used methodologies and polymers 
in mucoadhesive drug delivery systems.
Uniterms: Mucoadhesion. Bioadhesion. Mucoadhesive systems. Drugs/delivery.
O efeito de fármacos pode ser potencializado através do desenvolvimento de novos sistemas de liberação 
como os sistemas mucoadesivos. Estes sistemas permanecem em contato íntimo com o tecido de absorção, 
as mucosas, liberando o fármaco no local de ação, com o consequente aumento da biodisponibilidade, 
podendo promover efeitos locais e sistêmicos. A mucoadesão, atualmente, é explicada por seis teorias, 
a eletrônica, da adsorção, da molhabilidade, da difusão, da fratura e a mecânica. Para estudar seus 
mecanismos e quantificá-la, são propostas várias metodologias in vitro e in vivo. Porém, a mucoadesão 
ainda não é totalmente compreendida. Esse trabalho tem por objetivo revisar os mecanismos e as teorias 
envolvidas na mucoadesão, além de descrever as metodologias e os polímeros mais utilizados em sistemas 
mucoadesivos para liberação de fármacos.
Unitermos: Mucoadesão. Bioadesão. Sistemas mucoadesivos. Fármacos/liberação.
INTRODUCTION
The effect of a drug can now be reinforced as a result 
of the development of new release systems. Controlled re-
lease consists of techniques that make the active chemical 
agents available for a target, providing an adequate release 
rate and duration to produce the desired effect. The main 
controlled drug delivery systems currently available include 
matrices, pellets, floating systems, liposomes, microemul-
sions, liquid crystals, solid dispersions, nanosuspensions, 
transdermal systems, cyclodextrin inclusion complexes, 
osmotic pumps and bioadhesive systems (Wise, 2000).
Bioadhesion can be defined as the state in which two 
materials, at least one of which is biological in nature, are 
maintained together for a prolonged time period by means 
of interfacial forces (Smart, 2005). During the 1980s, this 
concept began to be applied to drug delivery systems. It 
consists of the incorporation of adhesive molecules into 
some kind of pharmaceutical formulation intended to 
stay in close contact with the absorption tissue, releasing 
the drug near to the action site, thereby increasing its 
bioavailability and promoting local or systemic effects 
(Hägerström, 2003; Woodley, 2001). An extensive review 
on mucoadhesive systems was compiled by Andrews, 
Laverty and Jones (2008).
The potential use for mucoadhesive systems as drug 
carriers lies in its prolongation of the residence time at 
the absorption site, allowing intensified contact with the 
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epithelial barrier (Hägerström, 2003). On the other hand, 
adhesion of preparations onto mucous membrane can be 
impaired by the mucociliary clearance system. This clea-
rance, a natural defense mechanism of the body against the 
deposition of impurities onto the mucous membrane, can 
also remove the preparation. Thus, by using bioadhesive 
molecules, it is possible to retain the preparation at the 
action site and to direct the drug to a specific site or tissue. 
Other features associated with the development of control-
led drug delivery systems using bioadhesive molecules 
include a decrease in drug administration frequency and 
an increase in patient compliance to the therapy (Woodley, 
2001). Therefore, a bioadhesive system controlling drug 
release could improve the treatment of diseases, helping 
to maintain an effective concentration of the drug at the 
action site (Huang et al., 2000).
Mucous membrane is the main administration site for 
bioadhesive systems, although the need for new bioadhe-
sive formulations for dermal administration has also been 
reported when prolonged cutaneous action is desired. A 
prolonged effect upon the dermal administration of creams, 
solutions, and lotions is unexpected, since such preparations 
can be easily removed from the skin by moisture, tempera-
ture, and physical movements (Shin et al., 2003).
Mucousl membranes of human organism are relati-
vely permeable and allow fast drug absorption (Jasti, Li, 
Cleary, 2003). They are characterized by an epithelial layer 
whose surface is covered by mucus. The mucus contains 
glycoproteins, lipids, inorganic salts and 95% water by 
mass, making it a highly hydrated system. Mucin is the 
most important glycoprotein of mucus and is responsible 
for its structure. The main functions of mucus are protec-
ting and lubricating the epithelium and other additional 
functions depending on the epithelium covered. Mucus 
thickness can vary from 50-450 µm in the stomach to less 
than 1 µm in the oral cavity (Smart, 2005). The mucous 
site most used for drug administration and absorption is 
gastrointestinal (Junginger, Thanou, Verhoef, 2002), but 
other routes, including nasal, ocular, buccal, vaginal, rec-
tal, oral, and periodontal have also been studied (Bruschi 
et. al. 2008, Bruschi, 2007; Hägerström, 2003; Woodley, 
2001).
Bioadhesive systems applied to mucous membrane 
are frequently defined as mucoadhesive, but the terms are 
interchangeable (Leung, Robinson, 1990). It is feasible to 
design a bio(muco)adhesive system in different dosage for-
ms, since the properties of adhesion largely depend on the 
features of the material used in its preparation (Evangelista, 
2006). Therefore, several conventional drug delivery sys-
tems already in use can become bioadhesive after redesign 
by including bioadhesive substances in their formulation. 
This approach to confer Bioadhesion properties has been 
widely applied in the development of a number of drug de-
livery systems. Solid micro- and nano-particulate systems 
based on chitosan and derivatives have been the focus of 
several studies (Bravo-Osuna et al., 2007; Wittaya-Areekul, 
Kruenate, Prahsarn, 2006): microemulsions are thermo-
dynamically stable and isotropic liquid systems, which 
allow the incorporation of bioadhesive molecules, such as 
polycarbophil (Vyas et al., 2006); colloidal dispersions of 
bioadhesive polymers frequently used in preparations for 
oral hygiene (Kockisch et al., 2001); semi-solid systems, 
as liquid crystalline mesophases (Bruschi et al., 2007, 
2008) and hydrogels (Bruschi et al., 2007; Huang et al., 
2000), which can increase the contact time between pre-
paration and mucous membrane after they undergo in situ 
gelation.
There are a number of materials used for developing 
such systems. The most studied materials are the polymers 
derived from polyacrylic acid, such as polycarbophil 
and carbomers, polymers derived from cellulose, such 
as hydroxyethylcellulose and carboxymethylcellulose, 
alginates, chitosan and derivatives and more recently, 
lectins and their derivatives (Grabovac, Guggi, Bernkop-
Schnürch, 2005; Smart, 2005).
Although studies on the mechanisms involved in 
mucoadhesion and the development of novel mucoadhesi-
ve systems and polymers have evolved over the last twenty 
years, mucoadhesion is not yet fully understood. Quantita-
tive and qualitative techniques are still treated separately. 
The aim of this study was to systematically review the 
mechanisms and theories involving mucoadhesion, as 
well as to describe the methods and polymers most used 
in mucoadhesive systems for drug delivery.
MECHANISMS OF MUCOADHESION
The mechanism of adhesion of certain macro-
molecules to the surface of a mucous tissue is not well 
understood yet. The mucoadhesive must spread over the 
substrate to initiate close contact and increase surface 
contact, promoting the diffusion of its chains within the 
mucus. Attraction and repulsion forces arise and, for a 
mucoadhesive to be successful, the attraction forces must 
dominate. Each step can be facilitated by the nature of the 
dosage form and how it is administered. For example, a 
partially hydrated polymer can be adsorbed by the subs-
trate because of the attraction by the surface water (Lee, 
Park, Robinson et al., 2000).
Thus, the mechanism of mucoadhesion is generally 
divided in two steps, the contact stage and the consolida-
tion stage (Figure 1). The first stage is characterized by 
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the contact between the mucoadhesive and the mucous 
membrane, with spreading and swelling of the formu-
lation, initiating its deep contact with the mucus layer 
(Hägerstrom, 2003). In some cases, such as for ocular or 
vaginal formulations, the delivery system is mechanically 
attached over the membrane. In other cases, the deposition 
is promoted by the aerodynamics of the organ to which the 
system is administered, such as for the nasal route. On the 
other hand, in the gastrointestinal tract direct formulation 
attachment over the mucous membrane is not feasible. 
Peristaltic motions can contribute to this contact, but the-
re is little evidence in the literature showing appropriate 
adhesion. Additionally, an undesirable adhesion in the 
esophagus can occur. In these cases, mucoadhesion can 
be explained by peristalsis, the motion of organic fluids 
in the organ cavity, or by Brownian motion. If the particle 
approaches the mucous surface, it will come into contact 
with repulsive forces (osmotic pressure, electrostatic re-
pulsion, etc.) and attractive forces (van der Waals forces 
and electrostatic attraction). Therefore, the particle must 
overcome this repulsive barrier (Smart, 2005).
In the consolidation step (Figure 1), the mucoadhe-
sive materials are activated by the presence of moisture. 
Moisture plasticizes the system, allowing the mucoadhe-
sive molecules to break free and to link up by weak van 
der Waals and hydrogen bonds (Smart, 2005). Essentially, 
there are two theories explaining the consolidation step: 
the diffusion theory and the dehydration theory. According 
to diffusion theory, the mucoadhesive molecules and the 
glycoproteins of the mucus mutually interact by means 
of interpenetration of their chains and the building of 
secondary bonds (Smart, 2005). For this to take place the 
mucoadhesive device has features favoring both chemical 
and mechanical interactions. For example, molecules with 
hydrogen bonds building groups (–OH, –COOH), with an 
anionic surface charge, high molecular weight, flexible 
chains and surface-active properties, which induct its spre-
ad throughout the mucus layer, can present mucoadhesive 
properties (Mathiowitz, Chickering, Lehr, 1999).
According to dehydration theory, materials that are 
able to readily gelify in an aqueous environment, when 
placed in contact with the mucus can cause its dehydration 
due to the difference of osmotic pressure. The difference 
in concentration gradient draws the water into the formu-
lation until the osmotic balance is reached. This process 
leads to the mixture of formulation and mucus and can 
thus increase contact time with the mucous membrane. 
Therefore, it is the water motion that leads to the consoli-
dation of the adhesive bond, and not the interpenetration of 
macromolecular chains. However, the dehydration theory 
is not applicable for solid formulations or highly hydrated 
forms (Smart, 2005).
MUCOADHESION THEORIES
Although the chemical and physical basis of muco-
adhesion are not yet well understood, there are six classi-
cal theories adapted from studies on the performance of 
several materials and polymer-polymer adhesion which 
explain the phenomenon (Hägerström, 2003; Huang et 
al., 2000; Smart, 2005).
Electronic theory
Electronic theory is based on the premise that both 
mucoadhesive and biological materials possess opposing 
electrical charges. Thus, when both materials come into 
contact, they transfer electrons leading to the building of a 
double electronic layer at the interface, where the attractive 
forces within this electronic double layer determines the 
mucoadhesive strength (Mathiowitz, Chickering, Lehr, 
1999).
Adsorption theory
According to the adsorption theory, the mucoadhe-
sive device adheres to the mucus by secondary chemical 
interactions, such as in van der Waals and hydrogen bonds, 
electrostatic attraction or hydrophobic interactions. For 
example, hydrogen bonds are the prevalent interfacial for-FIGURE 1 – The two steps of the mucoadhesion process.
FIGURE 2 – Dehydration theory of mucoadhesion.
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ces in polymers containing carboxyl groups (Hägerström, 
2003; Huang et al., 2000; Lee, Park, Robinson, 2000; 
Smart, 2005). Such forces have been considered the most 
important in the adhesive interaction phenomenon (Smart, 
2005) because, although they are individually weak, a 
great number of interactions can result in an intense global 
adhesion (Mathiowitz, Chickering, Lehr, 1999).
Wetting theory
The wetting theory applies to liquid systems which 
present affinity to the surface in order to spread over it. 
This affinity can be found by using measuring techniques 
such as the contact angle. The general rule states that the 
lower the contact angle then the greater the affinity (Figure 
3). The contact angle should be equal or close to zero to 
provide adequate spreadability (Mathiowitz, Chickering, 
Lehr, 1999).
The spreadability coefficient, S
AB
, can be calculated 
from the difference between the surface energies γ
B
 and 
γ
A
 and the interfacial energy γ
AB
, as indicated in equation 
(1) (Smart, 2005).
                                                    (1)
The greater the individual surface energy of mucus 
and device in relation to the interfacial energy, the greater 
the adhesion work, W
A
, i.e. the greater the energy needed 
to separate the two phases (Smart, 2005).
                                                    (2)
Diffusion theory
Diffusion theory describes the interpenetration of 
both polymer and mucin chains to a sufficient depth to 
create a semi-permanent adhesive bond (Figure 4). It is 
believed that the adhesion force increases with the de-
gree of penetration of the polymer chains (Mathiowitz, 
Chickering, Lehr, 1999). This penetration rate depends 
on the diffusion coefficient, flexibility and nature of the 
mucoadhesive chains, mobility and contact time (Hägers-
tröm, 2003; Huang et al., 2000; Lee, Park, Robinson, 2000; 
Smart, 2005). According to the literature, the depth of in-
terpenetration required to produce an efficient bioadhesive 
bond lies in the range 0.2-0.5 µm. This interpenetration 
depth of polymer and mucin chains can be estimated by 
equation 3:
                                                                         (3)
where t is the contact time, and D
b
 is the diffusion coe-
fficient of the mucoadhesive material in the mucus. The 
adhesion strength for a polymer is reached when the depth 
of penetration is approximately equivalent to the polymer 
chain size (Mathiowitz Chickering, Lehr, 1999).
In order for diffusion to occur, it is important that 
the components involved have good mutual solubility, 
that is, both the bioadhesive and the mucus have similar 
chemical structures. The greater the structural similarity, 
the better the mucoadhesive bond (Mathiowitz Chickering, 
Lehr, 1999).
Fracture theory
This is perhaps the most-used theory in studies on 
the mechanical measurement of mucoadhesion (Mathio-
witz Chickering, Lehr, 1999). It analyses the force required 
to separate two surfaces after adhesion is established (Hä-
gerström, 2003; Smart, 2005). This force, s
m
, is frequently 
calculated in tests of resistance to rupture by the ratio of 
the maximal detachment force, F
m
, and the total surface 
area, A
0
, involved in the adhesive interaction (equation 4):
FIGURE 3 – Schematic diagram showing influence of contact 
angle between device and mucous membrane on bioadhesion.
FIGURE 4 – Secondary interactions resulting from interdiffusion 
of polymer chains of bioadhesive device and of mucus.
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                                                                           (4)
In a single component uniform system, the fracture 
force, s
j
, which is equivalent to the maximal rupture tensile 
strength, s
m
, is proportional to the fracture energy (g
c
), for 
Young’s module (E) and to the critical breaking length (c) 
for the fracture site, as described in equation 5:
                                                                (5)
Fracture energy (g
c
) can be obtained from the rever-
sible adhesion work, W
r
 (energy required to produce new 
fractured surfaces), and the irreversible adhesion work, W
i
 
(work of plastic deformation provoked by the removal of 
a proof tip until the disruption of the adhesive bond), and 
both values are expressed as units of fracture surface (A
f
).
                                                                  (6)
The elastic module of the system (E) is related to the 
stress (s) and to the shear (e) by Hooke’s law:
                               (7)
In equation 7, the stress is the ratio between force 
(F) and area (A
0
), and shear is given by the ratio between 
the variation of system thickness (Dl) and the original 
thickness (l
0
).
A criticism of this analysis is that the system under 
investigation must have known physical dimensions and 
should be constituted by a single and uniform material. In 
virtue of this, the relationship obtained cannot be applied 
to analyze the fracture site of a multiple component bioa-
dhesive. In this case, the equation should be expanded to 
accommodate elastic dimensions and modules for each 
component. Besides, it must be considered that a failure of 
adhesion will occur at the bioadhesive interface. However, 
it has been demonstrated that the rupture rarely occurs 
at the surface, but near it (Mathiowitz Chickering; Lehr, 
1999) or at the weakest point, which can be the interface 
itself, the mucus layer or the hydrated region of the mucus, 
as illustrated in Figure 5 (Smart, 2005).
Since the fracture theory is concerned only with the 
force required to separate the parts, it does not take into ac-
FIGURE 5 – Regions where the mucoadhesive bond rupture 
can occur.
count the interpenetration or diffusion of polymer chains. 
Consequently, it is appropriate for use in the calculations 
for rigid or semi-rigid bioadhesive materials, in which 
the polymer chains do not penetrate into the mucus layer 
(Mathiowitz Chickering, Lehr, 1999).
Mechanical theory
Mechanical theory considers adhesion to be due 
to the filling of the irregularities on a rough surface by a 
mucoadhesive liquid. Moreover, such roughness increa-
ses the interfacial area available to interactions thereby 
aiding dissipating energy and can be considered the most 
important phenomenon of the process (Peppas, Sahlin, 
1996; Smart, 2005).
It is unlikely that the mucoadhesion process is the 
same for all cases and therefore it cannot be described by 
a single theory. In fact, all theories are relevant to identify 
the important process variables (Lee, Park, Robinson, 
2000).
The mechanisms governing mucoadhesion are also 
determined by the intrinsic properties of the formulation 
and by the environment in which it is applied (Lee, Park, 
Robinson, 2000). Intrinsic factors of the polymer are related 
to its molecular weight, concentration and chain flexibility. 
For linear polymers, mucoadhesion increases with molecu-
lar weight, but the same relationship does not hold for non-
linear polymers. It has been shown that more concentrated 
mucoadhesive dispersions are retained on the mucous mem-
brane for longer periods, as in the case of systems formed by 
in situ gelification. After application, such systems spread 
easily, since they present rheological properties of a liquid, 
but gelify as they come into contact the absorption site, thus 
preventing their rapid removal. Chain flexibility is critical 
to consolidate the interpenetration between formulation and 
mucus (Lee, Park, Robinson, 2000).
Environment-related factors include pH, initial 
contact time, swelling and physiological variations. The 
pH can influence the formation of ionizable groups in 
polymers as well as the formation of charges on the mucus 
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surface. Contact time between mucoadhesive and mucus 
layer determines the extent of chain interpenetration. 
Super-hydration of the system can lead to build up of 
mucilage without adhesion. The thickness of the mucus 
layer can vary from 50 to 450 µm in the stomach (Smart, 
2005) to less than 1µm in the oral cavity. Other physiolo-
gical variations can also occur with diseases (Lee, Park, 
Robinson, 2000).
None of these mechanisms or theories alone can 
explain the mucoadhesion which occurs in an array of 
different situations. However, the understanding of these 
mechanisms in each instance can help toward the deve-
lopment of new mucoadhesive products (Smart, 2005).
MUCOADHESIVE MATERIALS
The first study presenting the use of a mucoadhesive 
material was conducted by Nagai, and proposed an im-
proved treatment for stomatitis by using adhesive tablets. 
Additionally, an increase in the systemic bioavailability 
of insulin was observed in the form of bioadhesive pow-
der after nasal administration in dogs (Nagai et al.,1984; 
Nagai, 1985). Thereafter, bioadhesive materials have been 
used as absorption promoters for several administration 
routes. Earlier experiments were also done with known 
polymers available on the market, such as polyacrylic 
acids. Currently, the latest research is seeking to develop 
materials that direct the formulation more specifically to 
the action site and that can offer other functions besides 
mucoadhesion such as control over permeation within 
epithelial tissues, and inactivation of enzymes which can 
compromise release system action (Hägerström, 2003). 
First generation mucoadhesive materials 
These materials are natural or synthetic hydrophilic 
molecules containing numerous organic functions that 
generate hydrogen bonds such as carboxyl, hydroxyl 
and amino groups, which do not adhere specifically onto 
several surfaces. The very first use of mucoadhesive was 
as denture fixers and the most known examples are car-
bomers, chitosans, alginates and cellulose derivatives. 
They can be incorporated into solid formulations, such 
as tablets, transdermal adhesives and microparticles, and 
into semisolid formulations including gels, ointments, 
pastes and suppositories (Smart, 2005). These polymers 
can be subdivided into three classes: cationic, anionic and 
nonionic.
Cationic molecules can interact with the mucus 
surface, since it is negatively charged at physiological 
pH. Mucoadhesion of cationic polymers such as chitosan, 
occurs because of the electrostatic interactions of their 
amino groups with the sialic groups of mucin in the mu-
cus layer. Chitosan is a semi-synthetic polymer obtained 
by the deacetylation of chitin and has been extensively 
investigated as a drug delivery mucoadhesive systems 
(Woodley, 2001). Studies have demonstrated that chitosan 
can promote the absorption of hydrophilic molecules by 
the structural reorganization of the proteins associated to 
the intercellular junctions (Bravo-Osuna et al., 2007). The 
presence of chitosan at the surface of nanoparticles clearly 
increased their intestinal mucoadhesive behavior in rats 
(Bravo-Osuna et al., 2007). Bocataj et al. (2003) demons-
trated in their studies that chitosan showed higher mucoa-
dhesion than carboxymethylcellulose and polycarbophil.
In contrast, synthetic polymers derived from polya-
crylic acid (carbomers) are negatively charged but are 
also mucoadhesive. In this case, mucoadhesion results 
from physical-chemical processes, such as hydrophobic 
interactions, hydrogen and van der Waals bonds, which are 
controlled by pH and ionic composition (Woodley, 2001). 
Polyacrylic acid hydrogels have been extensively studied 
as mucoadhesive systems. Their chains are flexible and 
have non-abrasive characteristics when in the partially 
hydrated state, which decreases the tissue damage caused 
by friction when they come into contact (Huang et al., 
2000). The majority of polyacrylic acid derivatives are 
not water soluble, such as polycarbophil, but form viscous 
gels when hydrated (Woodley, 2001). Other examples of 
anionic polymers are carboxymethylcellulose and algi-
nates. The alginates, negatively charged polysaccharides, 
are widely used in the production of microparticles and 
are frequently reported as polyanionic mucoadhesive 
polymers (Wittaya-Areekul, Kruenate, Prahsarn, 2006).
Nonionic polymers, including hydroxypropylme-
thylcellulose, hydroxyethylcellulose and methylcellulose, 
present weaker mucoadhesion force compared to anionic 
polymers (Mortazavi, Moghimi, 2003).
There is a new class of substances being identified 
as bioadhesive. This class consists of ester groups of fatty 
acids, such as glyceryl monooleate and glyceryl mono-
linoleate, able to build liquid crystals which in turn can 
act as controlled release systems. These fatty acids build 
lyotropic liquid crystalline mesophases in the presence 
of water at body temperature. Liquid crystals can be 
considered structures of micelles ordered in a molecular 
arrangement characterized by alternate hydrophobic and 
hydrophilic regions. Different liquid-crystalline forms 
including lamellar, hexagonal, and cubic can be built as 
the surfactant concentration increases (Malmsten, 2002). 
Cubic phase favors the controlled release of drugs, since 
it has a structure made up of tridimensional curved lipid 
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bilayers, separated by congruent water channels. This 
structure has the appearance of highly viscous transparent 
gel. Due to this relatively high viscosity, it is difficult to ad-
minister on any mucous membrane. In order to circumvent 
the administration problems, a less viscous mesophase, 
e.g., the lamellar phase, can be used. In these instances this 
phase is considered a precursor of the cubic phase. In the 
case of lyotropic mesophases, the precursor absorbs water 
in situ and spontaneously builds the cubic phase (Bruschi 
et al., 2007; Nielsen, Schubert, Hansen, 1998).
Some hydrogels do not build liquid crystals but are 
able to gelify in situ after exposure to an external stimulus. 
These are the so-called environmental sensitive polymers 
and are classified as thermosensitive, e.g. poloxamers 
and carbomers (Bruschi et al., 2007; Park et al., 2001), 
pH sensitive, e.g. polyacrylic acid, presenting increased 
viscosity at higher pH values, glucose sensitive, e.g. poly-
mers linked to concavalin A, electric signal sensitive e.g. 
polymethacrylic acid, light sensitive, like hyaluronic acid 
(Qiu, Park, 2001) or ionic concentration sensitive, such 
as gellan gum (Hagerstrom et al., 2000). All these stimuli 
are found in the organism, making these polymers of great 
potential for use in the design of controlled release systems 
(Qiu, Park, 2001).
Mucoadhesion for gels formed by both liquid 
crystals and by environmental sensitive polymers can be 
explained by their rheological properties. These properties 
decrease the mucociliar clearance and increase the con-
tact time of the formulation with the mucous membrane 
(Bruschi et al., 2007; Nielsen, Schubert, Hansen, 1998).
Second generation mucoadhesive materials 
Studies on novel mucoadhesive systems involve 
the use of multifunctional materials. An ideal polymer 
should exhibit the ability to incorporate both hydrophilic 
and lipophilic drugs, show mucoadhesive properties in its 
solid and liquid forms, inhibit local enzymes or promote 
absorption, be specific for a particular cellular area or site, 
stimulate endocytosis and finally to have a broad safety 
range (Lee, Park, Robinson, 2000).
These novel multifunctional mucoadhesive systems 
are classified as second generation polymers (Lee, Park, 
Robinson, 2000). They are an alternative to non-specific 
bioadhesives (Smart, 2005) because they bind or adhere to 
specific chemical structures on the cell or mucus surface. 
Good examples of these molecules are lectins, invasins, 
fimbrial proteins (Woodley, 2001), antibodies (Chowdary, 
Rao, 2004), and those obtained by the addition of thiol 
groups to known molecules (Bravo-Osuna et al., 2007).
Lectins are immunogenic vegetal glycoproteins that 
specifically recognize sugar molecules. They are able to 
non-covalently bind to glycosilated components of the 
cellular membrane but not of the mucus, and adhesion can 
therefore be called cytoadhesion. Through the transmis-
sion of a cellular signal, this specific bond can result not 
only in bioadhesion but also in cellular internalization by 
different lysosomal and non-lysosomal mechanisms (Lehr, 
2000). The most commonly found lectins are those isola-
ted from Abrus precatroius, Agaricus bisporus, Anguilla 
anguilla, Arachis hypogaea, Pandeiraea simplicifolia, and 
Bauhinia purpurea (Chowdary, Rao, 2004).
Bacterial invasins are proteins from the membrane 
of Yersinia pseudotuberculosis that stimulate fagocytosis 
at cellular membrane through linkage with integrin recep-
tors (Chowdary, Rao, 2004; Lehr, 2000; Woodley, 2001).
Bacterial fimbrial proteins are able to adhere to the 
epithelial surface of erythrocytes. This adhesion is related 
to the pathogenicity of the bacteria. Bacterial adhesive 
factors can be an efficient mechanism of improving 
adhesion of mucoadhesive agents used in release systems 
(Chowdary, Rao, 2004).
Antibodies can be produced against selected mo-
lecules present on the mucus surface. Due to their high 
specificity, antibodies can be a rational choice as polymeric 
ligand in the development of site-specific mucoadhesives. 
This strategy can be useful for instance, in drugs targeting 
tumor tissues (Chowdary, Rao, 2004).
Thiolated polymers are obtained by the addition of 
conjugated sulfidryl groups (Grabovac, Guggi, Bernkop-
Schnürch, 2005). Bravo-Osuna et al. (2007) showed that 
thiolated chitosan increased mucoadhesive properties due 
to formation of disulfide bridges with cystein domains of 
glycoproteins of the mucus. Additionally, these products 
promoted mucus permeation by a mechanism of gluta-
thione regeneration. Finally, they possess antiprotease 
activity due to their binding ability with divalent cations, 
such as zinc and magnesium, which are co-factors for 
many proteases. All these characteristics make thiolated 
chitosan a promising material for administering peptides 
and proteins in mucous membrane (Bravo-Osuna et al., 
2007). Another study, carried out by Grabovac, Guggi, 
and Bernkop-Schnürch (2005) established a ranking of 
the most studied polymers, showing that both thiolated 
chitosan and polycarbophil are the most mucoadhesive.
Currently, the addition of elements of sensitization 
and recognition continue being used for the design of 
polymers with more intelligent mechanisms of mucoadhe-
sion. By binding functional groups within polymer chains, 
hydrogels can be made more sensitive to surrounding 
environmental conditions like temperature, moisture, pH, 
electrical fields and ionic forces (Peppas, Huang, 2004).
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Huang et al. (2000) proposed a mechanism in 
which units of the release system can specifically bind 
at the target surface. Certain amino acid sequences have 
complementary chains at mucous membrane and cellular 
surface. On contact with the mucous membrane, they can 
promote adhesion by binding to specific glycoproteins on 
this surface. Using this same mechanism, in the case of 
some diseases, changes occur in the glycoproteins, which 
can be attacked by complementary amino acid sequen-
ces linked to a release system, therefore increasing the 
affinity for diseased cells. The major problem with this 
strategy is finding the glycoproteins and their alterations 
in case of diseases (Huang et al., 2000).
With the advent of more intelligent mucoadhesive 
materials, it is possible to offer a unique carrying characte-
ristic for many drugs (Huang et al., 2000). These can be de-
signed for adhering onto any mucous membrane, for exam-
ple ocular, buccal, respiratory, urinary, or gastrointestinal 
etc. Mucoadhesive materials can improve bioavailability, 
drug absorption and transport while reducing undesirable 
systemic effects. In summary, with these materials it is 
possible to develop novel systems for drugs currently used 
in therapy and to obtain new products at low cost.
METHODS OF ANALYZING MUCOADHE-
SION
No technology has still been developed specifically 
to analyze mucoadhesion. Most of the tests available were 
adapted from other preexisting techniques but are useful 
and necessary for selecting the promising candidates as 
mucoadhesives as well as in elucidating their mechanisms 
of action.
In vitro and ex vivo tests
In vitro/ex vivo tests are important in the develop-
ment of a controlled release bioadhesive system because 
they contribute to studies of permeation, release, com-
patibility, mechanical and physical stability, superficial 
interaction between formulation and mucous membrane 
and strength of the bioadhesive bond. These tests can si-
mulate a number of administration routes including oral, 
buccal, periodontal, nasal, gastrointestinal, vaginal and 
rectal. The in vitro and ex vivo tests most prevalent in the 
literature are reported below.
Techniques utilizing gut sac of rats
The everted gut sac technique is an example of an 
ex vivo method. It has been used since 1954 to study in-
testinal transport. Santos et al. (1999) applied this method 
on mucoadhesion assays. It is easy to reproduce and can 
be performed in almost all laboratories. Figure 6 schema-
tically represents the technique. A segment of intestinal 
tissue is removed from the rat, everted, and one of its ends 
sutured and filled with saline. The sacs are introduced 
into tubes containing the system under analysis at known 
concentrations, stirred, incubated and then removed. The 
percent adhesion rate of the release system onto the sac 
is determined by subtracting the residual mass from the 
initial mass (Santos et al., 1999). 
Other techniques use non-everted gut sac. Takeuchi 
et al. (2005) filled rats’ intestines with liposome suspen-
sions. The sacs were sealed and incubated in saline. After 
a stipulated time, the number of liposomes adhered before 
(N
0
) and after (N
s
) incubation was assessed with a coulter 
counter and the percent mucoadhesive was expressed by 
equation 8 (Takeuchi et al., 2005).
                      (8)
The mucoadhesive effect of a system can also be 
evaluated by increases in gastrointestinal transit. Goto et 
al., 2006 incorporated fluorescent tracers into a system 
and quantified them by fluorescence spectroscopy in the 
stomach and intestinal mucus as a function of time.
Tests measuring mucoadhesive strength
Most in vitro/ex vivo methodologies found in the 
literature are based on the evaluation of mucoadhesive 
strength, that is, the force required to break the binding 
between the model membrane and the mucoadhesive. 
FIGURE 6 – Everted gut sac procedure.
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Depending on the direction in which the mucoadhesive 
is separated from the substrate, is it possible to obtain the 
detachment, shear, and rupture tensile strengths (Hägers-
tröm, 2003), as indicated in Figure 7.
The force most frequently evaluated in such tests is 
rupture tensile strength (Bromberg et al., 2004; Bruschi 
et al., 2007; Hägerström, 2003). Generally, the equipment 
used is a texture analyzer (Figure 8) or a universal testing 
machine. In this test, the force required to remove the for-
mulation from a model membrane is measured, which can 
be a disc composed of mucin (Bruschi et al., 2007), a piece 
of animal mucous membrane, generally porcine nasal 
mucus (Hägerström, 2003) or intestinal mucus from rats 
(Bromberg et al., 2004). Based on results, a force-distance 
curve can be plotted which yields the force required to 
detach the mucin disc from the surface with the formu-
lation (Bruschi et al., 2007), the tensile work (area under 
the curve during the detachment process), the peak force 
and the deformation to failure (Hägerström, 2003). This 
method is more frequently used to analyze solid systems 
like microspheres (Chowdary, Rao, 2004), although there 
are also studies on semi-solid materials (Bromberg et al., 
2004; Bruschi et al., 2007).
In addition to rupture tensile strength, the texture 
analyzer can also, as inferred by its name, evaluate the 
texture of the formulations and assess other mechanical 
FIGURE 7 – Different forces evaluated in mucoadhesion tests.
FIGURE 8 – Bioadhesion test using the texture analyzer.
properties of the system. A mobile arm containing an 
analytical probe forces down into a sample held in a flask 
placed on the equipment’s platform. Speed rate, time and 
depth are preset. From the resulting force-time and force-
distance plots, it is possible to calculate the hardness (force 
required to reach a given deformation), compressibility 
(work required to deform the product during the com-
pression), and adhesiveness (work required to overcome 
the attraction forces between the surfaces of sample and 
probe). Using this technique, it is possible to perform a 
previous evaluation of the material’s adhesive capacity, 
evidencing mucoadhesion properties (Bruschi, 2006).
Mucoadhesion strength can also be measured in 
terms of shear strength. This test measures the force 
required to separate two parallel glass slides covered 
with the polymer and with a mucus film (Bruschi, Frei-
tas, 2005; Chowdary, Rao, 2004). This can also be done 
using Wilhemy’s model (Figure 9), in which a glass plate 
is suspended by a microforce balance and immersed in a 
sample of mucus under controlled temperature. The force 
required to pull the plate out of the sample is then measu-
red under constant experimental conditions (Ahuja, Khar, 
Ali, 1997). Although measures taken by this method are 
reproducible, the technique involves no biological tissue 
and therefore does not provide a realistic simulation of 
biological conditions (Wong, Yuen, Peh, 1999).
Wilhemy’s plate technique, or the microforce ba-
lance technique, can also be modified in order to measure 
the specific adhesion force of microparticles (Chowdary, 
Rao, 2004; Hägerström, 2003). This involves the use of 
a microtensiometer and a microforce balance (Figure 10) 
and is specific, yielding both contact angle and surface 
tension. The mucous membrane is placed in a small mo-
bile chamber with both pH and physiological temperature 
controlled. A unique microsphere is attached by a thread to 
the stationary microbalance. The chamber with the mucous 
FIGURE 9 – Apparatus to determine mucoadhesion in vitro, 
using Wilhemy’s technique.
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membrane is raised until it comes into contact with the 
microsphere and, after contact time, is lowered back to 
the initial position (Mathiowitz, Chickering, Lehr, 1999). 
Following the trajectory, and with the aid of softwa-
re, results can be obtained for several parameters such as 
fracture strength, deformation and rupture tensile strength, 
from a load versus deformation curve, as shown in Figure 
11 (Mathiowitz, Chickering, Lehr, 1999).
The microforce balance is not indicated for micros-
pheres smaller than 300 μm, but has the advantage of 
simulating physiological conditions and providing results 
at a more microscopic level, besides being more reprodu-
cible and sensitive (Mathiowitz, Chickering, Lehr, 1999).
Rheological methods
This category of methods are all carried out in vitro 
and were first proposed by Hassan and Gallo (1990), who 
used viscosimetric assays to macroscopically analyze the 
formulation-mucin interaction. From this test, it is possi-
ble to obtain the mucoadhesion force by monitoring the 
viscosimetric changes of the system constituted by the 
mixture of the polymer chosen and mucin. The energy of 
the physical and chemical bonds of the mucin-polymer 
interaction can be transformed into mechanical energy or 
work. This work, which causes the rearrangements of the 
macromolecules, is the basis of the change in viscosity. A 
way to analyze the coefficient of viscosity of a hydrophi-
lic dispersion containing mucin plus the mucoadhesive 
polymer is through the contribution of each component, 
which results in equation 9:
η
t  
= η
m 
 + η
p 
+ η
b                                                                                                                
(9)
where η
t 
is the coefficient of viscosity of the system, and 
η
m
 and η
p
 are the coefficients of viscosity of mucin and 
bioadhesive polymer, respectively. The bioadhesion com-
ponent, η
b
, can be obtained from equation 9, resulting in 
equation 10:
η
b  
= η
t 
 – η
m 
– η
p
                                                                 (10)
For equations 9 and 10 to be valid, all components 
should be measured at the same concentration, tempera-
ture, time and shear gradient. The bioadhesion force, F, is 
determined by equation 11:
F = η
b
s                                                                               (11)
where σ is the shear gradient.
The main disadvantage of this method is the 
breakdown of the polymer and mucin network under 
continuous flow. To avoid this problem, the method was 
adapted using oscillatory rheology (Callens et al., 2003; 
Hägerström, 2003). Based on the same assumption that 
the rheological response of polymer-mucin mixture should 
be greater than the contributions from the gel and isolated 
mucin, a parameter called rheological synergism can be 
obtained. This method is more advantageous than the 
original, since oscillatory rheology is a non-destructive 
technique and simultaneously measures viscosity and 
elastic behavior and can be used to determine mucoa-
dhesion between polymers and mucin (Callens et al., 
2003).
The evaluation of rheological synergism can be 
FIGURE 11 - a) Typical load versus deformation curve; b) 
Progression of forces applied for corresponding graph. 
a)
b)
F IGURE 10  –  Microbalance method for  measuring 
mucoadhesion.
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done through two types of oscillatory assays: stress 
sweep and frequency sweep (Ceulemans, Vinckier, 
Ludwig, 2002).
In stress sweep, the elastic (G´) and viscous (G´´) 
moduli are obtained under constant frequency. This is used 
to investigate the influence of stress on the dynamic mo-
dulus, which should be obtained in the linear viscoelastic 
region, that is, the region where the material response is 
characteristic for its microstructure. Above this region, 
the structure is destroyed. The magnitude of the moduli 
is a qualitative indication of the system structure. Three 
situations can be found for polymeric dispersion: G’>> G” 
for a chemically interconnected system, G’>G” for chains 
with secondary bonds, and G’≤ G” for dispersions with 
physically-bound molecules. The quantitative measure 
of rheological synergism (ΔG’) can be calculated either 
in relation to G’or G” (Callens et al., 2003; Ceulemans, 
Vinckier, Ludwig, 2002), as shown in equation 12.
                             (12)
In frequency sweep, stress is maintained constant. 
The structure of the system can remain intact during the 
assay if it is conducted in the linear viscoelastic region. 
Under constant stress and at low frequencies, better struc-
tured systems present greater elastic modulus than viscous 
modulus and both are independent of frequency. On a log-
log graph, they are represented by a constant straight line. 
For less organized systems, dynamic moduli are dependent 
on the frequency and a slope is observed. (Callens et al., 
2003; Ceulemans, Vinckier, Ludwig, 2002).
This test enables analysis of the dynamic viscoelas-
tic parameters corresponding to the same frequency as a 
function of polymer or mucin concentration, yielding the 
rheological behavior in relation to the concentration of the 
system constituents (Hägerström, 2003).
Hägerström (2003) reveals an alternative parameter 
of rheological synergism, called relative rheological sy-
nergism parameter (DG´
relative
), calculated from equation 13 
and with which it is possible to quantitatively compare the 
force of polymer-mucin mixture with the isolated polymer:
                             (13),
where DG´ is the rheological synergism, given by the di-
fference between elastic modulus of the mixture (DG´
mixture
) 
and the elastic modulus of the polymer (G´
p
).
However, DG´
relative
 has the disadvantage of a nega-
tive limit up to -1, while the positive values run to infi-
nity. Therefore, the magnitude of positive values cannot 
be compared with that of negative values. Thus, a new 
relative parameter was proposed called the logarithmic 
relation of elastic module (log G´), which is given by the 
ratio between elastic modulus of the mixture (G
mix
) and 
the elastic modulus of the polymer (G´
p 
), as indicated in 
equation 14.
                                                      (14)
This parameter offers the advantage that both po-
sitive and negative values have the same magnitude, and 
are therefore comparable. For instance, the value 1 means 
that G´ of the mixture is 10-fold greater than that of the 
isolated polymer (Hägerström, 2003).
Rheological tests are performed totally in vitro 
and consequently are conducted in combination with 
the rupture tensile strength test, most frequently used in 
studies on mucoadhesion. The experimental conditions 
of both tests differ and there are cases in which the te-
chniques are complementary. Rheology measures the 
mechanical properties of the system, i.e., the resistance 
against flow and deformation, assessing the changes the 
system undergoes in the presence of mucin. However, 
rheology does not provide any direct information on what 
occurs at the interface, because the two phases – mucin 
and polymer – are mixed together prior to the experi-
ment. In the rupture tensile strength test, the interface 
is artificially created. Even with this difference, when 
the mucin-polymer produces rheological synergism, a 
corresponding structure organization is observed at the 
mucoadhesive interface. The rupture tensile strength test 
can be applied to solids and semi-solids, while rheology 
is applicable to semi-solids and liquids. Experimental 
conditions are critical in the rupture tensile strength test 
and there are several variables (sample layer, hydration, 
time of hydration, sample load, time of loading, detach-
ment rate, etc.), which should be optimized and set in 
order to produce reproducible results. The reproducibility 
of rheological measures is reasonably good, since the 
measures are taken on already balanced mixtures; com-
position, pH, and temperature can be carefully controlled 
and therefore fewer repetitions are necessary to obtain 
statistically significant data. Thus, it can be concluded 
that both methods contribute to different extents toward 
explaining the mucoadhesive phenomenon, depending 
on the mucoadhesion mechanism involved, system type, 
polymer used, etc. (Mathiowitz, Chickering, Lehr, 1999; 
Hagerstrom, 2003).
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Tests analyzing molecular interactions involved in 
mucoadhesion
The general problem arising from methods that show 
the adhesion force and from the rheological methods is that 
the mucoadhesive response is seen macroscopically while 
the interactions occur at a microscopic level.
The use of low frequency dielectric spectroscopy 
represents an attempt to study gel-mucus interactions near 
the molecular level. It evaluates the possible physicoche-
mical interactions between molecules and glycoproteins 
of the mucus at the interface, which is considered the 
step preceding the formation of bonds during the muco-
adhesion process. This technique involves the study of 
material response to the application of an electrical field. 
A sinusoidal voltage is applied throughout the sample and 
the response is measured in function of the frequency. 
From the responses, the impedance or permittivity of the 
sample is obtained and the property of charges changing 
in the system can be determined (Hägerström, 2003). This 
technique can provide information about the compatibility 
between mucus and mucoadhesive system by means of the 
evaluation of the movement of the charged particles. This 
compatibility is achieved according to the ease with which 
the particle crosses the barrier between the gel and mucous 
membrane. The dielectric measures reveal information 
about the gel and the mucous membrane separately, and 
about the interface between them (Hägerström, Edsman, 
Strømme, 2003).
Since the mucoadhesion process can be a conse-
quence of interactions between the mucus layer and the 
mucoadhesive polymer, it is highly dependent upon the 
molecular structure, including its charge. It is also well 
known that glycoproteins molecules, which form the 
mucus structure, are negative at physiological pH. By 
means of zeta potential, it is possible to understand the 
polymer-mucin electrostatic interactions (Takeuchi et al., 
2005). The zeta potential of dispersion is defined as the 
potential between the liquid superficial layer surrounding 
the dispersed particle and the remaining solution volume. 
It is a measure of the net surface charge of particles in a 
dispersed system (Bocataj et al., 2003). In this test, the 
mucin particles are suspended in an appropriate buffer and 
mixed with a solution of the polymer. If the addition of 
the polymer changes the zeta potential value of the mucin 
particles, this can suggest greater affinity between polymer 
and mucin particles (Takeuchi et al., 2005).
Another technique being applied to evaluate mo-
lecular interactions is the optical biosensor, or resonant 
mirror biosensor technique. Sigurdsson, Loftsson and 
Lehr (2006) used this technique to measure the interaction 
between glycoproteins of the mucus and different poly-
mers. It allows the monitoring of any interaction between 
two unknown molecules in real time, since one of them 
can be immobilized with covalent or non-covalent on the 
system surface while the other remains in solution at the 
surface. The molecules in solution, when binding to the 
immobilized molecules, alter the refraction index of the 
medium and this change is detected by the screening of a 
laser beam. The results of this study suggested the need for 
a clearer definition of mucoadhesion, because they called 
into question the polymers that are swelling dependent 
and undergo in situ gelification, because they do not seem 
to interact with glycoproteins, although they are called 
mucoadhesives (Sigurdsson, Loftsson, Lehr, 2006).
Another test using the same principle, the Biacore test, 
was applied for the analysis of mucoadhesion by Takeuchi 
et al. (2005). This test is based on the passage of a mucin 
suspension through a sensor containing the immobilized 
polymer. When a mucin particle binds to the polymer at 
the sensor, both the solute concentration and the refraction 
index on this surface undergo changes, where the interaction 
is quantitatively evaluated and reproduced on a diagram. 
The sensor is a chip with a glass surface covered in a fine 
gold layer, where functional groups are introduced and the 
polymer is attached (Takeuchi et al., 2005).
Imaging methods
Optical microscopes offer insufficient resolution 
for studying effects at a molecular level. For such inves-
tigations, a resolution at micro- or nanometric level is 
needed. Electronic microscopy gives a larger view, but 
the environmental conditions in which the sample must be 
submitted are far from the physiological conditions. For 
instance, the samples are analyzed in a vacuum chamber 
and generally are covered with a metallic film to avoid 
changes caused by the electronic rays (Mathiowitz, Chi-
ckering, Lehr, 1999).
Atomic force microscopy (AFM) is a relatively new 
technique that overcomes such restrictions, because it can 
be used under any environmental conditions, in air, liquids 
or vacuum. It enlarges more than 109-fold, which enables 
visualization of isolated atoms and offers a tridimensional 
image of the surface. The equipment (Figure 12, left side) 
has a support combined with a probe perpendicularly at-
tached to it. This tip moves toward a plane parallel to the 
sample, acquiring its topographic characteristics and the 
tip position is recorded by an optic deflection system: a 
laser beam is reflected onto the support and its position is 
then further reflected by a mirror reaching a photodiode 
sensor. A force-distance curve is plotted to measure the 
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forces between this tip and the surface of interest (Mathio-
witz, Chickering, Lehr, 1999). This curve is then used in 
bioadhesion studies. This entails coating the tip in adhesive 
material, which is generally spherical in shape (Figure 12, 
right side) and then the interaction with the surface, in this 
case the mucous membrane, can be measured (Cleary, 
Bromberg, Magner, 2004).
Besides AFM, there are other techniques using 
photographic images, such as fluorescence microscopy 
and confocal laser scanning microscopy (CSLM). Results 
achieved in ex vivo tests like the non-everted gut sac test 
(Keely et al., 2005), can be better visualized with this 
technique. Using radioisotopes or radioactive markers, 
it is possible to trace the polymer or the substance to be 
incorporated into the release system, where their location 
is visualized on the specific microscope, after the excision 
of the membrane. Takeuchi et al. (2005) used CSLM to 
analyze liposomes formulated with a fluorescent tracer and 
administered by the oral route in rats. The intestines were 
removed at an appropriate time after administration and 
the retention of the formulation was verified through the 
images achieved on the confocal microscope.
In the specific case of bioadhesive microspheres, 
the greater difficulty in their development is the sensi-
tive quantification of the bioadhesive interactions under 
physiological conditions. Several techniques are being 
developed to measure the adhesion of great volumes in 
this kind of sample and others to offer more qualitative 
data. The previously described microforce balance me-
thodology was an attempt to circumvent this difficulty. In 
parallel, another technology was developed, Electromag-
netic Force-transduction (EFT). In addition to information 
about bioadhesive forces, this technology also offers the 
simultaneous video image of the interactions, with high 
resolution and under physiological conditions. Figure 
FIGURE 12 – Constituents of AFM and the adaptations made 
for measuring the adhesive force between polymer and mucus 
surface. Adapted from Cleary, Bromberg and Magner, (2004), 
Mathiowitz, Chickering and Lehr (1999).
13 schematically illustrates the technique. The mucous 
membrane is mounted in a compartment under physiolo-
gical conditions and the microsphere is positioned directly 
below the magnetic probe. The compartment is slowly 
moved down, in an opposite direction to the probe, and 
the video camera is used to detect sphere movement. 
According to the movement, the control system increases 
the magnetic current and the resulting magnetic force (F
m
) 
pulls the sphere to its initial position, separating it from 
the tissue. After the experiment, the magnetic current is 
converted into force and the computer calculates the para-
meters of adhesion. The mucous membrane to be analyzed 
can be attained after an experiment using an everted gut 
sac (Mathiowitz, Chickering, Lehr, 1999).
An alternative technique which also uses a video 
camera is the flow-channel method. A fine glass channel is 
filled with an aqueous bovine submaxillary mucin solution 
maintained at 37 ºC and humid air is passed through the 
channel. A particle of the bioadhesive polymer is placed in 
the mucin gel and both the static and dynamic behaviors 
are monitored by the camera at frequent time intervals 
(Ahuja, Khar, Ali, 1997).
Falling Liquid Film Method
Nielsen, Schubert and Hansen (1998) used a me-
thod proposed by Rango Rao and Buri (1989) in which 
the chosen mucous membrane is placed in a stainless 
steel cylindrical tube, which has been longitudinally cut. 
This support is placed inclined in a cylindrical cell with 
a temperature controlled at 37 ºC. An isotonic solution is 
pumped through the mucous membrane and collected in a 
beaker (Figure 14). Subsequently, in the case of particulate 
systems, the amount remaining on the mucous membrane 
can be counted with the aid of a coulter counter (Chowda-
ry, Rao, 2004). For semi-solid systems, the non adhered 
FIGURE 13 - Elements of EFT. Adapted from Mathiowitz, 
Chickering and Lehr (1999).
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mucoadhesive can be quantified by high performance 
liquid chromatography (Nielsen, Schubert, Hansen, 1998). 
In this later case, porcine stomach, intestinal and buccal 
mucus were tested, and also jejunum from rabbits. The 
validation of this method showed that the type of mucus 
used does not influence the results. The release systems 
tested were precursors of liquid crystals constituted by 
monoglycerides. This methodology allows the visuali-
zation of formation of liquid-crystalline mesophase on 
the mucous membrane after the flowing of the fluids and 
through analysis by means of polarized light microscopy 
(Nielsen, Schubert, Hansen, 1998).
In vivo tests
There is scant information available on the in vivo 
behavior of mucoadhesive formulations, especially in 
humans. Säkkinen et al. (2006) applied gamma scintigra-
phy to analyze mucoadhesion in vivo of chitosan within 
the gastrointestinal tract. Gamma scintigraphy allows the 
immediate visualization of all the formulation transit, 
with low exposure of the subjects to radiation. The study 
emphasized the importance of in vivo studies, because 
although chitosan exhibits an outstanding mucoadhesion 
capacity in vitro, the retention time at the absorption site 
in the human gastrointestinal tract was relatively short and 
not sufficiently reproducible (Säkkinen et al., 2006). The 
gastrointestinal transit time in animals can also be evalu-
ated in a non-invasive way, in which the release systems 
can be formulated with opaque radioisotopes and signals 
can be followed by X-rays, without affecting normal gas-
trointestinal motility (Chowdary, Rao, 2004).
The number of methodologies applied to analyze 
mucoadhesion is constantly growing, although the use 
of different methods may sometimes lead to incoherence 
among results due to the heterogeneity of parameters and 
conditions used (Sigurdsso, Loftsson, Lehr, 2006). Ahuja 
et al. (1997) examined various studies that used the tension 
resistance method and each had employed different models 
of mucous membrane and equipment. Despite the large 
body of evidence obtained to date, further investigations 
aimed at standardizing the methodologies are warranted.
CONCLUSIONS
Studies on mucoadhesive systems have focused on 
a broad array of aspects. It is a growth area whose goal is 
the development of new devices and more “intelligent” 
polymers, as well as the creation of new methodologies 
that can better elucidate the mucoadhesion phenomenon. 
With the great influx of new molecules stemming from 
drug research, mucoadhesive systems may play an incre-
asing role in the development of new pharmaceuticals.
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